ArticleOncoimmunology2022

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness.

Elena Poli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.